Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Expert Review of Neurotherapeutics|December 3, 2013
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practiceCarlo Pozzilli
European Neurology|January 25, 2014
Overview of MS spasticityCarlo Pozzilli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Clinical markers of therapeutic response to disease modifying drugsCarlo Pozzilli, Luca Prosperini
Expert Opinion on Pharmacotherapy|April 26, 2006
Sex hormones: a role in the control of multiple sclerosis?Valentina Tomassini, Carlo Pozzilli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 22, 2021
Long-term fingolimod treatment in two pediatric patients with multiple sclerosisGiovanna Borriello, Carlo Pozzilli
Multiple Sclerosis International|June 15, 2013
The clinical relevance of force platform measures in multiple sclerosis: a reviewLuca Prosperini, Carlo Pozzilli
Expert Opinion on Investigational Drugs|July 2, 2003
Pharmacological methods to overcome IFN-beta antibody formation in the treatment of multiple sclerosisFrancesca Bagnato, Carlo Pozzilli
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2012
Assessing walking disability in multiple sclerosisBernd C Kieseier, Carlo Pozzilli
Expert Opinion on Pharmacotherapy|April 30, 2010
Treating multiple sclerosis with fingolimod or intramuscular interferonCarlo Pozzilli, Luca Prosperini, Giovanna Borriello
Therapeutics and Clinical Risk Management|September 22, 2010
Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tabletsClaudio Gasperini, Serena Ruggieri, Carlo Pozzilli
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Expert Review of Neurotherapeutics|December 3, 2013
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practiceCarlo Pozzilli
European Neurology|January 25, 2014
Overview of MS spasticityCarlo Pozzilli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Clinical markers of therapeutic response to disease modifying drugsCarlo Pozzilli, Luca Prosperini
Expert Opinion on Pharmacotherapy|April 26, 2006
Sex hormones: a role in the control of multiple sclerosis?Valentina Tomassini, Carlo Pozzilli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 22, 2021
Long-term fingolimod treatment in two pediatric patients with multiple sclerosisGiovanna Borriello, Carlo Pozzilli
Multiple Sclerosis International|June 15, 2013
The clinical relevance of force platform measures in multiple sclerosis: a reviewLuca Prosperini, Carlo Pozzilli
Expert Opinion on Investigational Drugs|July 2, 2003
Pharmacological methods to overcome IFN-beta antibody formation in the treatment of multiple sclerosisFrancesca Bagnato, Carlo Pozzilli
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2012
Assessing walking disability in multiple sclerosisBernd C Kieseier, Carlo Pozzilli
Expert Opinion on Pharmacotherapy|April 30, 2010
Treating multiple sclerosis with fingolimod or intramuscular interferonCarlo Pozzilli, Luca Prosperini, Giovanna Borriello
Therapeutics and Clinical Risk Management|September 22, 2010
Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tabletsClaudio Gasperini, Serena Ruggieri, Carlo Pozzilli
Pageof 25